Abstract
Fragile X syndrome (FXS) is a neurodevelopmental disorder resulting from a CGG repeat expansion in the untranslated portion of the fragile X mental retardation 1 (FMR1) gene that causes absence of the FMR1 protein, fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that regulates the protein production of a number of other genes that are critical for proper brain development and function. The high incidence of autism spectrum disorders (ASDs) in individuals with FXS, accompanied by the fact that FXS is responsible for 2–6 % of cases of ASD, has led researchers to examine the possibility of a common neurobiological mechanism that may underlie both conditions. We now know that many of the genes that are regulated by FMRP are also genes that are implicated in some individuals with ASD, providing evidence for a common molecular mechanism between FXS and a subset of cases of ASD. These studies have mutually informed our understanding of FXS and ASD and resulted in the advancement of targeted pharmacological treatments that may benefit FXS and non-FXS forms of ASD. This chapter provides a broad summary of the association between FXS and ASD, including diagnostic, genetic, molecular, and clinical aspects of the each disorder.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbeduto L, Hagerman RJ. Language and communication in fragile X syndrome. Ment Retard Dev Disabil Res Rev. 1997;3(4):313–22.
Amaral DG, Schumann CM, et al. Neuroanatomy of autism. Trends Neurosci. 2008;31(3):137–45.
Antar LN, Afroz R, et al. Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and Fmr1 mRNA localization differentially in dendrites and synapses. J Neurosci. 2004;24(11):2648–55.
Bailey A, Bolton P, et al. Prevalence of the fragile X anomaly amongst autistic twins and singletons. J Child Psychol Psychiatry. 1993;34(5):673–88.
Bailey Jr DB, Mesibov GB, et al. Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord. 1998;28(6):499–508.
Bailey DBJ, Raspa M, et al. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet. 2008;146A:2060–9.
Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60(2):201–14.
Baumgardner TL, Reiss AL, Freund LS, Abrams MT. Specification of the neurobehavioral phenotype in males with fragile X syndrome. Pediatrics. 1995;95(5):744–52.
Beckett L, Qilu Y, et al. The impact of fragile X: prevalence, numbers affected, and economic impact. A white paper prepared for the National Fragile X Foundation; 2005.
Bhakar AL, Dölen G, et al. The pathophysiology of fragile X (and What It Teaches Us about Synapses). Annu Rev Neurosci. 2012;35(1):417–43.
Blomquist HK, Bohman M, et al. Frequency of the fragile X syndrome in infantile autism. A Swedish multicenter study. Clin Genet. 1985;27(2):113–7.
Bolton P, Macdonald H, et al. A case–control family history study of autism. J Child Psychol Psychiatry. 1994;35(5):877–900.
Brown WT, Jenkins EC, et al. Autism is associated with the fragile-X syndrome. J Autism Dev Disord. 1982;12(3):303–8.
Budimirovic DB, Kaufmann WE. What can we learn about autism from studying fragile X syndrome? Dev Neurosci. 2011;33(5):379–94.
Chonchaiya W, Au J, et al. Increased prevalence of seizures in boys who where probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet. 2012;131(4):581–9.
Clifford S, Dissanayake C, et al. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord. 2007;37(4):738–47.
Comery TA, Harris JB, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA. 1997;94(10):5401–4.
Constantino JN, Zhang Y, et al. Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry. 2010;167(11):1349–56.
Cornish KM, Munir F, et al. The nature of the spatial deficit in young females with Fragile-X syndrome: a neuropsychological and molecular perspective. Neuropsychologia. 1998;36(11):1239–46.
Cornish KM, Munir F, et al. Spatial cognition in males with Fragile-X syndrome: evidence for a neuropsychological phenotype. Cortex. 1999;35(2):263–71.
Cornish KM, Munir F, et al. Differential impact of the FMR-1 full mutation on memory and attention functioning: a neuropsychological perspective. J Cogn Neurosci. 2001;13(1):144–50.
Cornish K, Sudhalter V, et al. Attention and language in fragile X. Ment Retard Dev Disabil Res Rev. 2004;10(1; Special Issue: Fragile X Syndrome: Frontiers of Understanding Gene-Brain-Behavior Relationships):11–6.
Crawford DC, Meadows KL, et al. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002;110(3):226–33.
Crowe SF, Hay DA. Neuropsychological dimensions of the fragile X syndrome: support for a non-dominant hemisphere dysfunction hypothesis. Neuropsychologia. 1990;28(1):9–16.
Darnell JC, Van Driesche SJ, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146(2):247–61.
De Rubeis S, Bagni C. Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability. Mol Cell Neurosci. 2010;43(1):43–50.
Farzin F, Whitney D, et al. Contrast detection in infants with fragile X syndrome. Vision Res. 2008;48(13):1471–8.
Fatemi SH, Folsom TD. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology. 2011;60(7–8):121–1226.
Fatemi SH, Kneeland RE, et al. Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res. 2010;124(1–3):246–7.
Feng Y, Gutekunst C, et al. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci. 1997;27(5):1539–47.
Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2006;12(1):2–22.
Fu YH, Kuhl DP, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67(6):1047–58.
Garrett AS, Menon V, et al. Here’s looking at you, kid: neural systems underlying face and gaze processing in fragile X syndrome. Arch Gen Psychiatry. 2004;61(3):281–8.
Hagerman RJ. Physical and behavioral phenotype. In: Hagerman RJ, Hagerman PJ, editors. Fragile X syndrome: diagnosis, treatment and research. 3rd ed. Baltimore: The Johns Hopkins University Press; 2002. p. 3–109.
Hagerman RJ, Chudley AE, et al. Autism in fragile X females. Am J Med Genet. 1986;23:375–80.
Hall SS, Lightbody AA, et al. Autism in fragile X syndrome: a category mistake? J Am Acad Child Adolesc Psychiatry. 2010;49(9):921–33.
Hallmayer J, Cleveland S, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;76:E1–8.
Harris SW, Hessl D, et al. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008;113(6):427–38.
Hengst U, Cox LJ, et al. Functional and selective RNA interference in developing axons and growth cones. J Neurosci. 2006;26(21):5727–32.
Hoeft F, Walter E, et al. Neuroanatomical differences in toddler boys with fragile X syndrome and idiopathic autism. Arch Gen Psychiatry. 2011;68(3):295–305.
Iossifov I, Ronemus M, et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74(2):285–99.
Irwin SA, Galvez R, et al. Brain structure and functions of FMR1 protein. In: Hagerman RJ, Hagerman PJ, editors. Fragile X syndrome: diagnosis, treatment and research. 3rd ed. Baltimore: The Johns Hopkins University Press; 2002. p. 191–205.
Jacquemont S, Curie A, et al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med. 2011;3(64):64ra61.
Kates WR, Folley BS, et al. Cerebral growth in fragile X syndrome: review and comparison with Down syndrome. Microsc Res Tech. 2002;57(3):159–67.
Loesch DZ, Huggins RM, et al. Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: a new perspective. Am J Med Genet. 2003;118(2):127–34.
Mazzocco MMM, Bhatia NS, et al. Visuospatial skills and their association with math performance in girls with fragile X or Turner Syndrome. Child Neuropsychol. 2006;12:87–110.
Munir F, Cornish KM, et al. A neuropsychological profile of attention deficits in young males with fragile X syndrome. Neuropsychologia. 2000;38:1261–70.
Rivera SM, Menon V, et al. Functional brain activation during arithmetic processing in females with fragile X Syndrome is related to FMR1 protein expression. Hum Brain Mapp. 2002;16(4):206–18.
Scerif G, Cornish K, et al. Visual search in typically developing toddlers and toddlers with fragile X or Williams syndrome. Dev Sci. 2004;7(1):116–30.
Scerif G, Karmiloff-Smith A, et al. To look or not to look? Typical and atypical development of oculomotor control. J Cogn Neurosci. 2005;17(4):591–604.
Scerif G, Cornish K, et al. Delineation of early attentional control difficulties in fragile X syndrome: focus on neurocomputational mechanisms. Neuropsychologia. 2007;45:1889–98.
Simon EW, Finucane BM. Facial emotion identification in males with fragile X syndrome. Am J Med Genet. 1996;67(1):77–80.
Sudhalter V, Belser RC. Conversational characteristics of children with Fragile X syndrome: tangential language. Am J Ment Retard. 2001;106(5):389–400.
Tassone F, Hagerman RJ, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84(3):250–61.
Turk J, Cornish K. Face recognition and emotion perception in boys with fragile-X syndrome. J Intellect Disabil Res. 1998;42(Pt 6):490–9.
Verkerk AJ, Pieretti M, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905–14.
Weiler IJ, Irwin SA, et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA. 1997;94(10):5395–400.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Farzin, F., Koldewyn, K. (2014). Fragile X Syndrome and Autism. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4788-7_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4787-0
Online ISBN: 978-1-4614-4788-7
eBook Packages: Behavioral Science